Direct replacement of oral sodium benzoate with glycerol phenylbutyrate in children with urea cycle disorders

Long‐term management of urea cycle disorders (UCDs) often involves unlicensed oral sodium benzoate (NaBz) which has a high volume and unpleasant taste. A more palatable treatment is licenced and available (glycerol phenylbutyrate [GPB], Ravicti) but guidance on how to transition patients from NaBz i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeo, Mildrid, Rehsi, Preeya, Dorman, Megan, Grunewald, Stephanie, Baruteau, Julien, Chakrapani, Anupam, Footitt, Emma, Prunty, Helen, McSweeney, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898712/
https://www.ncbi.nlm.nih.gov/pubmed/35281661
http://dx.doi.org/10.1002/jmd2.12274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898712/
https://www.ncbi.nlm.nih.gov/pubmed/35281661
http://dx.doi.org/10.1002/jmd2.12274

Ejemplares similares